United States Ex Rel. Colucci v. Beth Israel Medical Center

603 F. Supp. 2d 677, 2009 U.S. Dist. LEXIS 24894
CourtDistrict Court, S.D. New York
DecidedMarch 24, 2009
Docket06 Civ. 5033(DC)
StatusPublished
Cited by17 cases

This text of 603 F. Supp. 2d 677 (United States Ex Rel. Colucci v. Beth Israel Medical Center) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Ex Rel. Colucci v. Beth Israel Medical Center, 603 F. Supp. 2d 677, 2009 U.S. Dist. LEXIS 24894 (S.D.N.Y. 2009).

Opinion

OPINION

CHIN, District Judge.

Thomas Colucci, the relator in this False Claims Act (“FCA”) qui tam action, died in January 2008. The administrator of his estate, his widow Cleuza Colucci (“Coluc-ci”), moves for substitution as relator under Fed.R.Civ.P. 25(a). Defendants Beth Israel Medical Center (“BIMC”), Morton Hyman, Thomas Hayes, and Robert Naldi oppose the motion. For the reasons that follow, Colucci’s motion is granted and she is substituted as relator.

BACKGROUND

The relevant facts and procedural history are not in dispute.

On June 29, 2006, Thomas Colucci filed the complaint in this action under seal as relator on behalf of the United States. His complaint alleged defendants had violated the FCA by filing incorrect Medicare cost reports that resulted in intentional over-billing. (Compl. ¶ 3). A former independent consultant to BIMC, Thomas Co-lucci claimed personal knowledge of the events alleged in the complaint. (Id. ¶ 7).

The complaint was unsealed on September 13, 2007, and served on defendants in January 2008. Before defendants had time to respond to the complaint, however, Thomas Colucci died on January 24, 2008. On February 21, 2008, I stayed proceedings until such time as “an executor or administrator has been appointed to Mr. Colueci’s estate,” at which point the executor or administrator was to “advise the court as to whether he seeks to continue to prosecute this case.” (Feb. 21, 2008 Order).

Subsequently, in June 2008, Thomas Co-lucci’s widow notified the Court that she had been appointed administrator of her husband’s estate and that she sought substitution as relator in this action under Fed.R.Civ.P. 25(a). Colucci filed her mo *679 tion to substitute on July 17, 2008. Defendants filed their opposition on August 1, 2008, and Colucci filed her reply on September 15, 2008. The United States, which has declined to otherwise intervene in the action to date, submitted a statement of interest on September 25, 2008. The United States did not take a position on Colucci’s motion to substitute; its statement addressed only the question of whether the FCA is a punitive or remedial statute. Defendants replied to the United States’ statement on October 6, 2008.

DISCUSSION

This case presents an issue of first impression in the Second Circuit: whether a qui tam action under the FCA survives the death of the relator. If the answer is yes, the Court must then determine whether in this case Colucci, as administrator of her husband’s estate, may be substituted as relator.

A. The False Claims Act

The FCA was enacted in 1863 at the height of the Civil War primarily to “combat rampant fraud in Civil War defense contracts.” S.Rep. No. 99-345, at 8 (1986), as reprinted in 1986 U.S.C.C.A.N. 5266, 5273. As the Supreme Court has explained, the statute:

was originally adopted following a series of sensational congressional investigations into the sale of provisions and munitions to the War Department. Testimony before Congress painted a sordid picture of how the United States had been billed for nonexistent or worthless goods, charged exorbitant prices for goods delivered, and generally robbed in purchasing the necessities of war. Congress wanted to stop the plundering of the public treasury.

United States v. McNinch, 356 U.S. 595, 599, 78 S.Ct. 950, 2 L.Ed.2d 1001 (1958).

Accordingly, the FCA provides that:

[A]ny person who knowingly presents, or causes to be presented, to an officer or employee of the United States Government ... a false or fraudulent claim for payment or approval ... is liable to the United States Government for a civil penalty of not less than $5,000 and not more than $10,000, plus 3 times the amount of damages which the Government sustains because of the act of that person.

31 U.S.C. § 3729(a)(7).

The statute reaches not only the actual submission of a false claim, but also the making of a record or statement to obtain payment or approval of a false claim, the possession of property or money used to defraud the Government, illegal purchases from an officer or employee of the Government, and the making of a false record to “conceal, avoid or decrease” a financial obligation to the Government. See 31 U.S.C. § 3729(a)(2)-(7).

1. Qui Tam Provision

Under the qui tam provision of the FCA, a private person “may bring a civil action for violations of § 3729 for the person and for the United States Government.” 31 U.S.C. § 3730(b). These suits are brought in the name of the United States. Id. The plaintiff, or “relator,” must provide the Government with a copy of the complaint and written disclosure of all material evidence and information. 31 U.S.C. § 3730(b)(2). The complaint remains under seal for at least 60 days; during that time the Government decides to either: (a) proceed with the action; or (b) notify the court that it declines to take over the action, leaving the relator with the right to conduct the action. 31 U.S.C. § 3730(b), (c).

The relator is entitled to receive a portion of the damages paid in the action, *680 regardless of whether the Government proceeds with the action. 31 U.S.C. § 3730(d). This portion can range from ten to twenty-five percent of proceeds from the action or settlement of the claim. Id.

2. 1986 Amendments

In 1986, in response to the perception that “fraud permeates generally all Government programs,” Congress amended the FCA in significant respects. S.Rep. No. 99-345, at 2, as reprinted in 1986 U.S.C.C.A.N. at 5267. These amendments strengthened the Act by, among other things, increasing the mandatory civil remedies from double damages to treble damages and the fines from $2,000 to $5,000-$10,000 for each violation. 31 U.S.C. § 3729(a)(7). The amendments also expanded the rights of qui tarn relators and increased their financial incentives to bring suit under the Act, so as to “encourage more private enforcement suits.” See

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DeLeon v. Dunaway
S.D. New York, 2023
CFS 12 Funding LLC v. Wiesen
S.D. New York, 2022
United States v. Wiesel
E.D. New York, 2020
Sharp v. Ally Fin., Inc.
328 F. Supp. 3d 81 (W.D. New York, 2018)
People v. Sprint Nextel Corp.
42 N.E.3d 655 (New York Court of Appeals, 2015)
United States v. Tdc Mgt. Corp., Inc.
District of Columbia, 2014
Colucci v. Beth Israel Medical Center
531 F. App'x 118 (Second Circuit, 2013)
United States Ex Rel. Hood v. Satory Global, Inc.
946 F. Supp. 2d 69 (District of Columbia, 2013)
Securities & Exchange Commission v. Wyly
860 F. Supp. 2d 275 (S.D. New York, 2012)
United States Ex Rel. Colucci v. Beth Israel Medical Center
785 F. Supp. 2d 303 (S.D. New York, 2011)
United States Ex Rel. Drake v. NSI, Inc.
736 F. Supp. 2d 489 (D. Connecticut, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
603 F. Supp. 2d 677, 2009 U.S. Dist. LEXIS 24894, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-colucci-v-beth-israel-medical-center-nysd-2009.